Literature DB >> 21840628

Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastrophe.

Niamh M O'Boyle1, Miriam Carr, Lisa M Greene, Niall O Keely, Andrew J S Knox, Thomas McCabe, David G Lloyd, Daniela M Zisterer, Mary J Meegan.   

Abstract

The structure-activity relationships of antiproliferative β-lactams, focusing on modifications at the 4-position of the β-lactam ring, is described. Synthesis of this series of compounds was achieved utilizing the Staudinger and Reformatsky reactions. The antiproliferative activity was assessed in MCF-7 cells, where the 4-(4-ethoxy)phenyl substituted compound 26 displayed the most potent activity with an IC(50) value of 0.22 μM. The mechanism of action was demonstrated to be by inhibition of tubulin polymerisation. Cell exposure to combretastatin A-4 and 26 led to arrest of MCF-7 cells in the G2/M phase of the cell cycle and induction of apoptosis. Additionally, mitotic catastrophe for combretastatin A-4 and for 26 was demonstrated in breast cancer cells for the first time, as evidenced by the formation of giant, multinucleated cells.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840628     DOI: 10.1016/j.ejmech.2011.07.039

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Biological Evaluation in Vitro and in Silico of Azetidin-2-one Derivatives as Potential Anticancer Agents.

Authors:  Fabián E Olazaran; Gildardo Rivera; Alondra M Pérez-Vázquez; Cynthia M Morales-Reyes; Aldo Segura-Cabrera; Isaías Balderas-Rentería
Journal:  ACS Med Chem Lett       Date:  2016-11-10       Impact factor: 4.345

2.  Stereochemical preference toward oncotarget: Design, synthesis and in vitro anticancer evaluation of diastereomeric β-lactams.

Authors:  Fabián Olazarán-Santibáñez; Debasish Bandyopadhyay; Pilar Carranza-Rosales; Gildardo Rivera; Isaías Balderas-Rentería
Journal:  Oncotarget       Date:  2017-06-06

Review 3.  Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review.

Authors:  Eavan C McLoughlin; Niamh M O'Boyle
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.